Literature DB >> 33257773

Detection of SARS-CoV-2 in placental but not fetal tissues in the second trimester.

Jacob E Valk1, Alexander M Chong2, Anne-Catrin Uhlemann1, Larisa Debelenko3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33257773      PMCID: PMC7700914          DOI: 10.1038/s41372-020-00877-8

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


× No keyword cloud information.

To the Editor:

The data on placental and fetal involvement in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during pregnancy are limited. We analyzed placental and fetal tissues for the presence of SARS-CoV-2 in two infected women who presented with a miscarriage and a preterm labor in the second trimester. The study was approved by the Institutional Review Board. The tissues were studied by immunohistochemistry (IHC) using antibodies against SARS-CoV-2 spike (clone 1A9; GeneTex, Irvine, CA) and nucleocapsid (clone 0001; Sino Biological, Wayne, PA) proteins and in-situ hybridization (ISH) using the RNAscope-ProbeV-nCoV2019-S (Advanced-Cell-Diagnostics, Hayward, CA). Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was carried out using RNA extracted from formalin-fixed paraffin embedded tissues and SARS-CoV-2 primer/probe sets (Integrated DNA Technology, Coralville, Iowa). Each assay included a standard curve, using the 2019-nCoV_N_Positive Control (Integrated DNA Technology, Coralville, Iowa). Both women tested positive for SARS-CoV-2 by the nasopharyngeal swab test, but were asymptomatic for COVID-19 before, during or within 14 days after delivery. A 17 year-old gravida 1 para 0 presented with preterm premature rupture of membranes at 18+ weeks and delivered a non-viable female fetus. A 29 year-old gravida 1 para 0 presented in labor at 23+ weeks and delivered a male neonate with Apgar scores 2, 2, and 2. A cardiac arrest was registered on 8 min of life and resuscitation was unsuccessful. The neonatal nasal swab test for SARS-CoV-2 was negative. Placental and fetal pathologies as well as results of the tissue viral studies are presented in Table 1. SARS-CoV-2 qRT-PCR was positive in placentas and negative in fetal organs in both cases. Neither placentas, nor fetal organs stained for the virus by IHC and ISH. This discrepancy can be explained by a much lower sensitivity of IHC and ISH, comparing to RT-PCR. To date, we found at least ten reported cases of SARS-CoV-2 detected in the placental tissue by RT-PCR [1-5] and only in five cases was the virus demonstrated by IHC and/or ISH [2, 3].
Table 1

Clinical data and results of SARS-CoV-2 identification in placental and fetal/neonatal tissues.

Case #Clinical dataPlacental pathologyFetal/Neonatal pathologyTissue TestedqRT-PCRIHC clone 1A9IHC clone 001ISH
117 yo G1P0 GA 18 4/7 wkChronic deciduitis with plasma cellsIntrauterine growth restrictionPlacentaPositive Ct 33.06 VL 12,944NegativeNegative
Chlamydia infection, 1st trimesterDecidual hemosiderosisNegative for congenital anomaliesUmbilical cordNegativeNegative
Fetal lungsNegativeNegativeNegative
SARS-CoV-2-Normal karyotypeFetal heartNegativeNegativeNegative
positiveFetal liverNegativeNegative
Fetal kidneyNegativeNegativeNegative
COVID-19Fetal small intestineNegative
asymptomaticFetal ovary and Fallopian tubeNegative
229 yo G1P0 GA 23 2/7 wkAcute chorioamnionitisAcute pulmonary inflammatory infiltratePlacentaPositive Ct 39.20 VL 224NegativeNegative
SARS-CoV-2 positiveAcute chorionic and umbilical vasculitisGram-positive cocci within neutrophilsUmbilical cordNegativeNegative
Neonatal lungsNegativeNegativeNegative
COVID-19 asymptomaticPost-mortem lung cultures positive for GBSNeonatal spleen and adrenalNegativeNegative
Neonatal heartNegativeNegative
Neonatal liverNegativeNegative
Neonatal kidney and intestineNegativeNegative

GA gestational age, wk weeks, GBS Group B Streptococcus agalactiae, qRT-PCR quantitative reverse transcription polymerase chain reaction, Ct threshold cycle, VR viral load, IHC immunohistochemistry, clone 1A9 anti SARS-CoV-2 spike protein antibody, clone 001 anti SARS-CoV-2 nucleocapsid protein antibody, ISH in situ hybridization.

Clinical data and results of SARS-CoV-2 identification in placental and fetal/neonatal tissues. GA gestational age, wk weeks, GBS Group B Streptococcus agalactiae, qRT-PCR quantitative reverse transcription polymerase chain reaction, Ct threshold cycle, VR viral load, IHC immunohistochemistry, clone 1A9 anti SARS-CoV-2 spike protein antibody, clone 001 anti SARS-CoV-2 nucleocapsid protein antibody, ISH in situ hybridization. Lack of viral sequences in umbilical cords and fetal organs argues against a vertical transmission of SARS-CoV-2, while the presence of placental and fetal pathologies previously established to be associated with fetal demise can explain the abortion and the preterm labor. In the 1st case, the placenta showed chronic deciduitis (Supplementary Fig. 1), which is known to be associated with an abnormal immune response to pregnancy and spontaneous abortions with normal karyotype. In the 2nd case, placental and neonatal pulmonary pathologies provided a convincing evidence of involvement by Group B Streptococcus agalactiae (Supplementaty Fig. 2), a known cause of premature labor and neonatal death. We demonstrated SARS-CoV-2 involvement of placentas detectable by qRT-PCR in asymptomatic COVID-19-infected pregnant women in the second trimester. Our data are in accord with published reports on the low incidence of vertical transmission of the virus. However, more data are needed to determine the overall feto-maternal risks of SARS-CoV-2 infection at different terms of gestation. Figure 1. Placental Pathology, Case 1 Figure 2. Placental and Neonatal Pulmonary Pathology, Case 2 Supplementary Figures Captions
  4 in total

1.  A SARS-CoV-2 Delta Variant Case Manifesting as Extensive Placental Infection and Fetal Transmission.

Authors:  Wei-Bin Shen; Shifa Turan; Bingbing Wang; Liviu Cojocaru; Christopher Harman; James Logue; E Albert Reece; Matthew B Frieman; Peixin Yang
Journal:  Gynecol Obstet Invest       Date:  2022-05-06       Impact factor: 2.729

2.  Cellular and molecular atlas of the placenta from a COVID-19 pregnant woman infected at midgestation highlights the defective impacts on foetal health.

Authors:  Jingsi Chen; Lili Du; Feiyang Wang; Xuan Shao; Xiaoyi Wang; Wenzhe Yu; Shilei Bi; Dexiong Chen; Xingfei Pan; Shanshan Zeng; Lijun Huang; Yingyu Liang; Yulian Li; Rufang Chen; Fengwu Xue; Xiuying Li; Shouping Wang; Manli Zhuang; Mingxing Liu; Lin Lin; Hao Yan; Fang He; Lin Yu; Qingping Jiang; Zhongtang Xiong; Lizi Zhang; Bin Cao; Yan-Ling Wang; Dunjin Chen
Journal:  Cell Prolif       Date:  2022-02-09       Impact factor: 8.755

3.  Placental lesions and SARS-Cov-2 infection: Diffuse placenta damage associated to poor fetal outcome.

Authors:  Amine Bouachba; Fabienne Allias; Beatrice Nadaud; Jerome Massardier; Yahia Mekki; Maude Bouscambert Duchamp; Benoit De LA Fourniere; Cyril Huissoud; Alexis Trecourt; Sophie Collardeau-Frachon
Journal:  Placenta       Date:  2021-07-15       Impact factor: 3.481

4.  A standardized definition of placental infection by SARS-CoV-2, a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development SARS-CoV-2 Placental Infection Workshop.

Authors:  Drucilla J Roberts; Andrea G Edlow; Roberto J Romero; Carolyn B Coyne; David T Ting; Jason L Hornick; Sherif R Zaki; Upasana Das Adhikari; Lena Serghides; Stephanie L Gaw; Torri D Metz
Journal:  Am J Obstet Gynecol       Date:  2021-08-05       Impact factor: 8.661

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.